Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
SOPH
Sophia Genetics SA SOPH
$4.88
โ–ผ -6.15% 24H
1.936.3110.7015.0819.462021-072022-102024-012025-032026-06

About

Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven medicine, making genomic and other types of patient data insights accesโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryHealth Information Services
CountrySwitzerland
Employees415
TickerSOPH

Statistics

Market Cap$350.3M
Revenue (TTM)$76.2M
Net Incomeโ€”
Net Marginโ€”
EPSโ€”
P/E-4.19
P/S4.60
P/B8.18
EV/EBITDA-5.27
ROE-123.3%
Dividend Yieldโ€”
Price$4.88

Data: Twelve Data ยท Revenue = mcap / P/S

Sophia Genetics SA (SOPH) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap